Acorda Therapeutics Inc (ACORQ)
0.90
+0.20
(+28.57%)
USD |
OTCM |
May 21, 12:45
Acorda Therapeutics Debt to Equity Ratio: -1.031 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.031 |
| December 31, 2023 | -1.178 |
| September 30, 2023 | 3.071 |
| June 30, 2023 | 2.596 |
| March 31, 2023 | 2.228 |
| December 31, 2022 | 1.784 |
| September 30, 2022 | 2.477 |
| June 30, 2022 | 2.104 |
| March 31, 2022 | 1.430 |
| December 31, 2021 | 1.182 |
| September 30, 2021 | 1.066 |
| June 30, 2021 | 0.9047 |
| March 31, 2021 | 1.148 |
| December 31, 2020 | 0.9868 |
| September 30, 2020 | 0.7325 |
| June 30, 2020 | 0.7726 |
| March 31, 2020 | 0.7195 |
| December 31, 2019 | 0.7042 |
| September 30, 2019 | 1.249 |
| June 30, 2019 | 0.6417 |
| March 31, 2019 | 0.6115 |
| December 31, 2018 | 0.5617 |
| September 30, 2018 | 0.5704 |
| June 30, 2018 | 0.5588 |
| March 31, 2018 | 0.6142 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.6445 |
| September 30, 2017 | 0.4886 |
| June 30, 2017 | 0.4766 |
| March 31, 2017 | 0.4838 |
| December 31, 2016 | 0.4984 |
| September 30, 2016 | 0.4473 |
| June 30, 2016 | 0.4407 |
| March 31, 2016 | 0.4294 |
| December 31, 2015 | 0.4854 |
| September 30, 2015 | 0.5144 |
| June 30, 2015 | 0.5243 |
| March 31, 2015 | 0.5315 |
| December 31, 2014 | 0.5387 |
| September 30, 2014 | 0.5529 |
| June 30, 2014 | 0.574 |
| March 31, 2014 | 0.0072 |
| December 31, 2013 | 0.0099 |
| September 30, 2013 | 0.0102 |
| June 30, 2013 | 0.0106 |
| March 31, 2013 | 0.0109 |
| December 31, 2012 | 0.014 |
| September 30, 2012 | 0.024 |
| June 30, 2012 | 0.0253 |
| March 31, 2012 | 0.0263 |
| December 31, 2011 | 0.0311 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.178
Minimum
Dec 2023
3.071
Maximum
Sep 2023
1.180
Average
1.107
Median
Debt to Equity Ratio Benchmarks
| BioSig Technologies Inc | 0.00 |
| Verve Therapeutics Inc | 0.00 |
| Spectral AI Inc | 0.4341 |
| AIM ImmunoTech Inc | 0.5332 |
| Protalix BioTherapeutics Inc | 0.6856 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.58M |
| Total Liabilities (Quarterly) | 267.35M |
| Shareholders Equity (Quarterly) | -185.77M |
| Current Ratio | 0.2164 |
| Net Debt Paydown Yield | -29.79% |